Last 12 months
Inside the activity.
6 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 21 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 3 |
| Apr 2026 | 2 | 5 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2021 Filed Jun 16, 2021 20:17 UTC |
Roberts EvanChief Operating Officer
|
SaleCommon Stock | 16,486 | $55.91 | $921,768.53 |
DisclosureSEC source: 0001562180-21-004297 · primarydocument.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611,622 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.36 to $56.34 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:17 UTC |
CAHILL EDWARD LDirector
|
SaleCommon Stock | 2,054 | $57.90 | $118,936.05 |
DisclosureSEC source: 0001562180-21-004296 · primarydocument.xml · nonDerivative · entry 2 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,878 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.81 to $58.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:17 UTC |
CAHILL EDWARD LDirector
|
SaleCommon Stock | 12,946 | $57.40 | $743,101.69 |
DisclosureSEC source: 0001562180-21-004296 · primarydocument.xml · nonDerivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,932 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.81 to $57.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:24 UTC |
Pegus CherylDirector
|
Tax withholdingCommon Stock | 3,555 | $45.45 | $161,574.75 |
DisclosureSEC source: 0001562180-21-003745 · primarydocument.xml · nonDerivative · entry 1 Pegus Cheryl · CIK 0001572448 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,220 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:13 UTC |
Munson GillianDirector
|
SaleCommon Stock | 100 | $45.11 | $4,511.00 |
DisclosureSEC source: 0001562180-21-003484 · primarydocument.xml · nonDerivative · entry 2 Munson Gillian · CIK 0001592494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,381 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:13 UTC |
Munson GillianDirector
|
SaleCommon Stock | 1,677 | $44.39 | $74,442.20 |
DisclosureSEC source: 0001562180-21-003484 · primarydocument.xml · nonDerivative · entry 1 Munson Gillian · CIK 0001592494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,481 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.10 to $44.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 04, 2021 Filed May 5, 2021 22:54 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionStock Options (Right to buy) · Derivative | 22,755 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001562180-21-003274 · primarydocument.xml · derivative · entry 4 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,755 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 04, 2021 Filed May 5, 2021 22:54 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionStock Option · Derivative | 22,755 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001562180-21-003274 · primarydocument.xml · derivative · entry 3 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,755 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 04, 2021 Filed May 5, 2021 22:54 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionCommon Stock | 22,755 | $2.03 | $46,192.65 |
DisclosureSEC source: 0001562180-21-003274 · primarydocument.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 04, 2021 Filed May 5, 2021 22:54 UTC |
Linetsky DavidSVP, Life Sciences
|
Exercise / conversionCommon Stock | 22,755 | $0.84 | $19,114.20 |
DisclosureSEC source: 0001562180-21-003274 · primarydocument.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 04, 2021 Filed May 5, 2021 22:54 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 123,750 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001562180-21-003273 · primarydocument.xml · derivative · entry 2 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 123,750 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 04, 2021 Filed May 5, 2021 22:54 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 123,750 | $0.84 | $103,950.00 |
DisclosureSEC source: 0001562180-21-003273 · primarydocument.xml · nonDerivative · entry 1 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,248,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 04, 2021 Filed May 5, 2021 22:53 UTC |
Roberts EvanChief Operating Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 25,000 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001562180-21-003272 · primarydocument.xml · derivative · entry 2 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 25,000 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| May 04, 2021 Filed May 5, 2021 22:53 UTC |
Roberts EvanChief Operating Officer
|
Exercise / conversionCommon Stock | 25,000 | $0.84 | $21,000.00 |
DisclosureSEC source: 0001562180-21-003272 · primarydocument.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:13 UTC |
CAHILL EDWARD LDirector
|
GrantCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003137 · primarydocument.xml · nonDerivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,878 F1 · shares: Granted as a result of director's election to receive deferred stock units in lieu of an annual cash retainer pursuant to the Issuer's Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock on the earlier of (i) 90 days after ceasing to serve as a member of the Board of Directors of Phreesia, Inc. and incurring a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder or (ii) five years from the date of grant of the deferred stock units. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:13 UTC |
Goldstein LainieDirector
|
GrantCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003136 · primarydocument.xml · nonDerivative · entry 1 Goldstein Lainie · CIK 0001399513 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,460 F1 · shares: Granted as a result of director's election to receive deferred stock units in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. Director shall receive underlying common stock 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a "separation from service" within the meaning fo Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder. F2 · balance_after: These shares represent RSUs. Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:12 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionStock Options (Right to buy) · Derivative | 5,688 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001562180-21-003135 · primarydocument.xml · derivative · entry 2 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,689 Underlying: Common Stock · 5,688 shares Expires 2029-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of this option vested and became exercisable on January 17, 2019, with the remainder vesting in three equal annual installments for the three years thereafter. Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:12 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionCommon Stock | 5,688 | $8.03 | $45,674.64 |
DisclosureSEC source: 0001562180-21-003135 · primarydocument.xml · nonDerivative · entry 1 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 17:08 UTC |
Davidoff Michael J.See Remarks
|
Exercise / conversionStock Options (Right to buy) · Derivative | 2,134 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001562180-21-002802 · primarydocument.xml · derivative · entry 4 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,111 Underlying: Common Stock · 2,134 shares Expires 2028-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 17:08 UTC |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 200 | $51.52 | $10,303.00 |
DisclosureSEC source: 0001562180-21-002802 · primarydocument.xml · nonDerivative · entry 3 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,589 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.38 to $51.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 17:08 UTC |
Davidoff Michael J.See Remarks
|
SaleCommon Stock | 1,934 | $50.40 | $97,481.14 |
DisclosureSEC source: 0001562180-21-002802 · primarydocument.xml · nonDerivative · entry 2 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,789 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.08 to $50.58 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 17:08 UTC |
Davidoff Michael J.See Remarks
|
Exercise / conversionCommon Stock | 2,134 | $4.71 | $10,051.14 |
DisclosureSEC source: 0001562180-21-002802 · primarydocument.xml · nonDerivative · entry 1 Davidoff Michael J. · CIK 0001777450 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:28 UTC |
CAHILL EDWARD LDirector
|
SaleCommon Stock | 6,152 | $55.22 | $339,722.67 |
DisclosureSEC source: 0001562180-21-002656 · primarydocument.xml · nonDerivative · entry 2 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,709 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.97 to $55.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:28 UTC |
CAHILL EDWARD LDirector
|
SaleCommon Stock | 8,848 | $54.75 | $484,392.61 |
DisclosureSEC source: 0001562180-21-002656 · primarydocument.xml · nonDerivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,861 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.97 to $54.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:28 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 300 | $61.31 | $18,393.00 |
DisclosureSEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 5 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,580 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.07 to $61.53 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:28 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 500 | $60.62 | $30,312.00 |
DisclosureSEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 4 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,880 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.07 to $61.02 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:28 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 778 | $58.51 | $45,518.99 |
DisclosureSEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 3 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,380 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.23 to $59.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:28 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 6,706 | $61.69 | $413,721.31 |
DisclosureSEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 2 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,158 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.50 to $62.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:28 UTC |
Linetsky DavidSVP, Life Sciences
|
SaleCommon Stock | 41,776 | $61.06 | $2,550,788.25 |
DisclosureSEC source: 0000899243-21-012177 · doc4.xml · nonDerivative · entry 1 Linetsky David · CIK 0001776729 · SVP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,864 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.50 to $61.47 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 19, 2021 Filed Feb 20, 2021 00:37 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 204 | $73.39 | $14,972.01 |
DisclosureSEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 5 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,879 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.36 to $73.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 19, 2021 Filed Feb 20, 2021 00:37 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 700 | $72.66 | $50,862.07 |
DisclosureSEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 4 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,083 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.28 to $72.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:51 UTC |
CAHILL EDWARD LDirector
|
SaleCommon Stock | 1,000 | $73.56 | $73,555.90 |
DisclosureSEC source: 0000899243-21-007463 · doc4.xml · nonDerivative · entry 3 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,709 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.29 to $73.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:51 UTC |
CAHILL EDWARD LDirector
|
SaleCommon Stock | 882 | $72.58 | $64,012.91 |
DisclosureSEC source: 0000899243-21-007463 · doc4.xml · nonDerivative · entry 2 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,709 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.26 to $73.21 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:51 UTC |
CAHILL EDWARD LDirector
|
SaleCommon Stock | 8,118 | $71.75 | $582,457.57 |
DisclosureSEC source: 0000899243-21-007463 · doc4.xml · nonDerivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,591 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.22 to $72.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:37 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 4,114 | $73.51 | $302,416.03 |
DisclosureSEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 3 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,783 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.14 to $73.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:37 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 11,413 | $72.37 | $826,009.03 |
DisclosureSEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 2 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,897 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.14 to $73.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 18, 2021 Filed Feb 20, 2021 00:37 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 60,745 | $71.77 | $4,359,923.78 |
DisclosureSEC source: 0000899243-21-007458 · doc4.xml · nonDerivative · entry 1 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,310 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.14 to $72.121 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:34 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0000899243-21-004203 · doc4.xml · derivative · entry 8 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,387 Underlying: Common Stock · 500 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:34 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,704 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0000899243-21-004203 · doc4.xml · derivative · entry 7 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,704 shares Expires 2023-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:34 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 354 | $67.44 | $23,875.39 |
DisclosureSEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 6 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,009 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.44 to $67.51 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:34 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 4,021 | $66.79 | $268,552.54 |
DisclosureSEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 5 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,363 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.41 to $67.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:34 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 14,304 | $65.81 | $941,291.88 |
DisclosureSEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 4 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,384 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.41 to $66.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:34 UTC |
VanDuyn Amy BethSVP, Human Resources
|
SaleCommon Stock | 3,150 | $65.09 | $205,042.64 |
DisclosureSEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 3 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,688 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.41 to $65.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:34 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionCommon Stock | 500 | $0.84 | $420.00 |
DisclosureSEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 2 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 21:34 UTC |
VanDuyn Amy BethSVP, Human Resources
|
Exercise / conversionCommon Stock | 17,704 | $0.84 | $14,871.36 |
DisclosureSEC source: 0000899243-21-004203 · doc4.xml · nonDerivative · entry 1 VanDuyn Amy Beth · CIK 0001776863 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 26, 2021 Filed Mar 17, 2025 20:36 UTC |
Roberts EvanChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001127602-25-009698 · form5.xml · derivative · entry 2 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects an option exercise that was not previously reported due to a vendor administrative oversight. Forms 4 filed after the date of exercise underreported total common stock holdings by 30,000 shares. F2 · derivative.exercise_date: This option was fully vested and exercisable as of the date of the reported transaction. Read SEC document |
| January 26, 2021 Filed Mar 17, 2025 20:36 UTC |
Roberts EvanChief Operating Officer
|
Exercise / conversionCommon Stock | 30,000 | $0.84 | $25,200.00 |
DisclosureSEC source: 0001127602-25-009698 · form5.xml · nonDerivative · entry 1 Roberts Evan · CIK 0001776704 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 794,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects an option exercise that was not previously reported due to a vendor administrative oversight. Forms 4 filed after the date of exercise underreported total common stock holdings by 30,000 shares. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 22:50 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 719 | $70.03 | $50,351.79 |
DisclosureSEC source: 0000899243-21-003334 · doc4.xml · nonDerivative · entry 2 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,055 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.77 to $70.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 22:50 UTC |
Altier ThomasChief Financial Officer
|
SaleCommon Stock | 776 | $69.37 | $53,832.28 |
DisclosureSEC source: 0000899243-21-003334 · doc4.xml · nonDerivative · entry 1 Altier Thomas · CIK 0001777448 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,774 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.77 to $69.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:34 UTC |
Indig ChaimDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,892 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0000899243-21-002981 · doc4.xml · derivative · entry 5 Indig Chaim · CIK 0001776732 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,658 Underlying: Common Stock · 14,892 shares Expires 2028-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 25% of this option vested and became exercisable on January 31, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.